Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionSUMO ligase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.50e-07201435GO:0061665
GeneOntologyMolecularFunctionGTPase activator activity

RGPD4 RGPD2 RANBP2 RGPD8 ARHGAP17 RGPD3 TBCK RINL ELMOD1 RASAL1 RGPD5

5.51e-0627914311GO:0005096
GeneOntologyMolecularFunctionSUMO transferase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

5.54e-06361435GO:0019789
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

RGPD4 RGPD2 RANBP2 RGPD8 FRMD7 ARHGAP17 DENND1C RGPD3 DENND2C TBCK RINL ELMOD1 RASAL1 RGPD5

1.72e-0550714314GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

RGPD4 RGPD2 RANBP2 RGPD8 FRMD7 ARHGAP17 DENND1C RGPD3 DENND2C TBCK RINL ELMOD1 RASAL1 RGPD5

1.72e-0550714314GO:0030695
GeneOntologyMolecularFunctionpeptidyl-prolyl cis-trans isomerase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.87e-05501435GO:0003755
GeneOntologyMolecularFunctionRNA polymerase I general transcription initiation factor activity

TAF1C RRN3P2 RRN3

2.93e-0591433GO:0001181
GeneOntologyMolecularFunctioncis-trans isomerase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.82e-05531435GO:0016859
GeneOntologyMolecularFunctioncore promoter sequence-specific DNA binding

TAF1C POLR2A RRN3P2 RRN3 TP53

4.58e-05551435GO:0001046
GeneOntologyMolecularFunctionRNA polymerase I core promoter sequence-specific DNA binding

TAF1C RRN3P2 RRN3

5.69e-05111433GO:0001164
GeneOntologyMolecularFunctionRNA polymerase I transcription regulatory region sequence-specific DNA binding

TAF1C RRN3P2 RRN3

9.76e-05131433GO:0001163
GeneOntologyMolecularFunctiondeacetylase activity

NDST4 SIRT4 SIRT1 NDST3

1.89e-04401434GO:0019213
GeneOntologyMolecularFunctionenzyme activator activity

RGPD4 RGPD2 RANBP2 RGPD8 TOPBP1 ARHGAP17 NLRC4 PIK3CA RGPD3 TBCK RINL ELMOD1 RASAL1 RGPD5

2.67e-0465614314GO:0008047
GeneOntologyMolecularFunctionhydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides

NDST4 SIRT4 SIRT1 FAAH NDST3

2.91e-04811435GO:0016811
GeneOntologyMolecularFunctionRNA polymerase I core binding

RRN3P2 RRN3

3.03e-0441432GO:0001042
GeneOntologyMolecularFunction[heparan sulfate]-glucosamine N-sulfotransferase activity

NDST4 NDST3

3.03e-0441432GO:0015016
GeneOntologyMolecularFunctionN-acetylglucosamine deacetylase activity

NDST4 NDST3

3.03e-0441432GO:0050119
GeneOntologyMolecularFunctionhistone H3K36me/H3K36me2 demethylase activity

KDM2B KDM2A

3.03e-0441432GO:0140680
GeneOntologyMolecularFunctionsmall GTPase binding

RGPD4 TNPO1 RGPD2 FLNA RANBP2 RGPD8 RASIP1 RGPD3 RINL

5.20e-043211439GO:0031267
GeneOntologyMolecularFunctionNAD-dependent protein lysine deacetylase activity

SIRT4 SIRT1

1.04e-0371432GO:0034979
GeneOntologyMolecularFunctionGTPase binding

RGPD4 TNPO1 RGPD2 FLNA RANBP2 RGPD8 RASIP1 RGPD3 RINL

1.17e-033601439GO:0051020
GeneOntologyMolecularFunctionATP-dependent activity

DNHD1 ABCA13 ABCB5 SPO11 CHD9 ATP10B RFC5 UBA7 ATP2C1 DNAH5 DHX29 TP53

1.57e-0361414312GO:0140657
GeneOntologyMolecularFunctiondinucleotide phosphatase activity

ENPP1 NUDT13

1.77e-0391432GO:0004551
GeneOntologyMolecularFunctionpotassium:chloride symporter activity

SLC12A6 SLC12A4

1.77e-0391432GO:0015379
GeneOntologyBiologicalProcesspositive regulation of glucokinase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.78e-0991425GO:0033133
GeneOntologyBiologicalProcessNLS-bearing protein import into nucleus

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

3.43e-09201426GO:0006607
GeneOntologyBiologicalProcesspositive regulation of hexokinase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.53e-09101425GO:1903301
GeneOntologyBiologicalProcessregulation of glucokinase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.77e-08131425GO:0033131
GeneOntologyBiologicalProcessregulation of hexokinase activity

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.74e-08141425GO:1903299
GeneOntologyBiologicalProcessprotein import into nucleus

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 RGPD8 RGPD3 TP53 RGPD5

1.02e-0619514210GO:0006606
GeneOntologyBiologicalProcesscarbohydrate biosynthetic process

RGPD4 RGPD2 FUT10 RANBP2 RGPD8 ENPP1 NDST4 ST3GAL4 SIRT1 NDST3 RGPD3

1.17e-0624714211GO:0016051
GeneOntologyBiologicalProcessimport into nucleus

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 RGPD8 RGPD3 TP53 RGPD5

1.34e-0620114210GO:0051170
GeneOntologyBiologicalProcessprotein peptidyl-prolyl isomerization

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.02e-06381425GO:0000413
GeneOntologyBiologicalProcessprotein localization to nucleus

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 RGPD8 MFHAS1 SIRT1 RGPD3 TP53 RGPD5

8.02e-0636214212GO:0034504
GeneOntologyBiologicalProcessregulation of gluconeogenesis

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3

9.49e-06711426GO:0006111
GeneOntologyBiologicalProcesscarbohydrate metabolic process

RGPD4 RGPD2 FUT10 RANBP2 RGPD8 PGGHG ENPP1 NDST4 ST3GAL4 ONECUT1 SIRT1 NDST3 PIK3CA RGPD3 FGGY TP53

9.98e-0664614216GO:0005975
GeneOntologyBiologicalProcessmonosaccharide metabolic process

RGPD4 RGPD2 FUT10 RANBP2 RGPD8 ONECUT1 SIRT1 PIK3CA RGPD3 FGGY TP53

1.03e-0531014211GO:0005996
GeneOntologyBiologicalProcessnucleolus organization

ZNF354A RRN3P2 SIRT1 RRN3

1.18e-05211424GO:0007000
GeneOntologyBiologicalProcessestablishment of protein localization to organelle

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 LRWD1 RGPD8 PEX13 SIRT4 RGPD3 TOMM40 TP53 RGPD5

1.33e-0551514214GO:0072594
GeneOntologyBiologicalProcessprotein localization to organelle

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 LRWD1 RGPD8 MFHAS1 TOPBP1 PEX13 SPO11 PCARE SIRT4 SIRT1 RGPD3 TOMM40 PRKCZ IFT80 TP53 RGPD5

1.85e-05109114221GO:0033365
GeneOntologyBiologicalProcesshexose metabolic process

RGPD4 RGPD2 FUT10 RANBP2 RGPD8 ONECUT1 SIRT1 PIK3CA RGPD3 TP53

2.81e-0528414210GO:0019318
GeneOntologyBiologicalProcesspeptidyl-proline modification

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.47e-05541425GO:0018208
GeneOntologyBiologicalProcessregulation of carbohydrate biosynthetic process

RGPD4 RGPD2 RANBP2 RGPD8 ENPP1 SIRT1 RGPD3

3.64e-051321427GO:0043255
GeneOntologyBiologicalProcessregulation of glucose metabolic process

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3 TP53

4.01e-051341427GO:0010906
GeneOntologyBiologicalProcessglucose metabolic process

RGPD4 RGPD2 RANBP2 RGPD8 ONECUT1 SIRT1 PIK3CA RGPD3 TP53

4.99e-052441429GO:0006006
GeneOntologyBiologicalProcessnuclear transport

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 RGPD8 AAAS RGPD3 TP53 RGPD5

6.34e-0537814211GO:0051169
GeneOntologyBiologicalProcessnucleocytoplasmic transport

RGPD4 TNPO1 TRAF3IP2 RGPD2 FLNA RANBP2 RGPD8 AAAS RGPD3 TP53 RGPD5

6.34e-0537814211GO:0006913
GeneOntologyBiologicalProcessgluconeogenesis

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3

1.20e-041111426GO:0006094
GeneOntologyBiologicalProcesshexose biosynthetic process

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3

1.46e-041151426GO:0019319
GeneOntologyBiologicalProcessmonosaccharide biosynthetic process

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3

1.92e-041211426GO:0046364
GeneOntologyBiologicalProcessregulation of intrinsic apoptotic signaling pathway by p53 class mediator

RRN3P2 SIRT1 RRN3 TP53

1.97e-04421424GO:1902253
GeneOntologyBiologicalProcessregulation of carbohydrate metabolic process

RGPD4 RGPD2 RANBP2 RGPD8 ENPP1 SIRT1 RGPD3 TP53

2.03e-042311428GO:0006109
GeneOntologyBiologicalProcesstranscription initiation at RNA polymerase I promoter

TAF1C RRN3P2 RRN3

2.42e-04181423GO:0006361
GeneOntologyBiologicalProcessnegative regulation of helicase activity

SIRT1 TP53

2.80e-0441422GO:0051097
GeneOntologyBiologicalProcessammonium import across plasma membrane

SLC12A6 SLC12A4

2.80e-0441422GO:0140157
GeneOntologyCellularComponentcytoplasmic periphery of the nuclear pore complex

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

7.97e-1081445GO:1990723
GeneOntologyCellularComponentnuclear pore cytoplasmic filaments

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.55e-09101445GO:0044614
GeneOntologyCellularComponentannulate lamellae

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.76e-08141445GO:0005642
GeneOntologyCellularComponentnuclear pore nuclear basket

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.15e-07181445GO:0044615
GeneOntologyCellularComponentnuclear inclusion body

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.06e-07201445GO:0042405
GeneOntologyCellularComponentSUMO ligase complex

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.69e-07211445GO:0106068
GeneOntologyCellularComponentnuclear pore

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3 CHMP3 RGPD5

4.91e-071011448GO:0005643
GeneOntologyCellularComponentnuclear protein-containing complex

RGPD4 RGPD2 FLNA RANBP2 LRWD1 RGPD8 TAF1C POLR2A TOPBP1 WDR83 PRPF6 RFC5 SIRT1 AAAS RGPD3 PWP2 CHMP3 KDM2B GINS2 INTS9 MED23 TP53 RGPD5

6.73e-05137714423GO:0140513
GeneOntologyCellularComponentinclusion body

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.97e-04901445GO:0016234
GeneOntologyCellularComponentnuclear envelope

RGPD4 RGPD2 RANBP2 VRK2 RGPD8 LRRC59 SIRT1 AAAS RGPD3 CHMP3 PRKCZ RGPD5

5.10e-0456014412GO:0005635
GeneOntologyCellularComponentapical dendrite

FLNA ENPP1 SEZ6

1.37e-03321443GO:0097440
GeneOntologyCellularComponentlysosomal membrane

LPCAT1 CYBRD1 ABCA13 ENPP1 ATP10B TLR7 VPS16 SLC12A4 CHMP3 TMEM150C

1.39e-0346214410GO:0005765
GeneOntologyCellularComponentlytic vacuole membrane

LPCAT1 CYBRD1 ABCA13 ENPP1 ATP10B TLR7 VPS16 SLC12A4 CHMP3 TMEM150C

1.39e-0346214410GO:0098852
MousePhenoelevated level of mitotic sister chromatid exchange

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.81e-07161215MP:0003701
MousePhenodecreased tumor latency

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

1.86e-07301216MP:0010308
MousePhenoabnormal tumor latency

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

4.10e-07341216MP:0010307
MousePhenoaneuploidy

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3 TP53

9.06e-07611217MP:0004024
MousePhenoabnormal morula morphology

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.54e-06261215MP:0012058
MousePhenofailure of blastocyst formation

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.35e-06311215MP:0012129
MousePhenoabnormal chromosome number

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3 TP53

9.33e-06861217MP:0004023
MousePhenoabnormal blastocyst formation

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.03e-05391215MP:0012128
MousePhenoincreased hepatocellular carcinoma incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

3.10e-05701216MP:0003331
MousePhenoincreased lung carcinoma incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

5.74e-05781216MP:0008714
MousePhenoincreased head mesenchyme apoptosis

ATP2C1 KDM2B

7.43e-0521212MP:0013199
MousePhenoincreased splenic marginal zone lymphoma incidence

TLR7 TP53

7.43e-0521212MP:0009318
MousePhenoabnormal rod electrophysiology

RGPD4 RGPD2 RANBP2 LPCAT1 RGPD8 PCARE RGPD3

7.69e-051191217MP:0004021
MousePhenoabnormal chromosome morphology

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 RGPD3 TP53

1.10e-041261217MP:0003702
MousePhenoincreased neural tube apoptosis

RRN3P2 ATP2C1 RRN3 KDM2B

1.80e-04331214MP:0012505
MousePhenoincomplete embryo turning

ELP1 RRN3P2 PTK7 RRN3 KDM2A

2.44e-04651215MP:0001701
MousePhenoincreased sarcoma incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

2.54e-041021216MP:0002032
MousePhenoincreased respiratory system tumor incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

3.29e-041071216MP:0010298
MousePhenoincreased lung tumor incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

3.29e-041071216MP:0008014
MousePhenofailure of blastocyst to hatch from the zona pellucida

RGPD4 RGPD2 RANBP2 RGPD8 TAF1C RGPD3

3.29e-041071216MP:0003694
MousePhenoincreased hepatobiliary system tumor incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

4.01e-041111216MP:0010297
MousePhenoincreased liver tumor incidence

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

4.01e-041111216MP:0008019
MousePhenoabnormal blastocyst hatching

RGPD4 RGPD2 RANBP2 RGPD8 TAF1C RGPD3

4.41e-041131216MP:0003693
DomainRan_BP1

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.36e-10121396PF00638
DomainRANBD1

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.36e-10121396PS50196
DomainRanBD

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

2.51e-10131396SM00160
DomainRan_bind_dom

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

2.51e-10131396IPR000156
DomainGrip

RGPD4 RGPD2 RGPD8 RGPD3 RGPD5

9.47e-09111395SM00755
DomainGRIP

RGPD4 RGPD2 RGPD8 RGPD3 RGPD5

9.47e-09111395PF01465
DomainGRIP_dom

RGPD4 RGPD2 RGPD8 RGPD3 RGPD5

1.61e-08121395IPR000237
DomainGRIP

RGPD4 RGPD2 RGPD8 RGPD3 RGPD5

1.61e-08121395PS50913
DomainRab_bind

RGPD4 RGPD2 RGPD8 RGPD3

1.01e-0771394PF16704
DomainGCC2_Rab_bind

RGPD4 RGPD2 RGPD8 RGPD3

1.01e-0771394IPR032023
Domain-

RGPD4 RGPD2 RGPD8 RGPD3

5.96e-071013941.10.220.60
DomainCUT

ONECUT1 ONECUT3 CUX1

1.38e-0571393PS51042
DomainCUT

ONECUT1 ONECUT3 CUX1

1.38e-0571393PF02376
DomainCUT_dom

ONECUT1 ONECUT3 CUX1

1.38e-0571393IPR003350
DomainCUT

ONECUT1 ONECUT3 CUX1

1.38e-0571393SM01109
DomainPH_dom-like

RGPD4 RGPD2 RANBP2 RGPD8 FRMD7 CNKSR2 NIBAN2 JAK3 PTPN4 RGPD3 EPB41 RASAL1 RGPD5

1.82e-0542613913IPR011993
DomainKCC1

SLC12A6 SLC12A4

5.50e-0521392IPR000622
DomainFA

FRMD7 PTPN4 EPB41

1.09e-04131393PF08736
DomainFERM-adjacent

FRMD7 PTPN4 EPB41

1.09e-04131393IPR014847
DomainFA

FRMD7 PTPN4 EPB41

1.09e-04131393SM01195
DomainTPR-contain_dom

RGPD4 RGPD2 RANBP2 RGPD8 PRPF6 RGPD3 RGPD5

1.32e-041501397IPR013026
DomainPHD_4

KDM2B KDM2A

1.64e-0431392PF16866
Domain-

RGPD4 RGPD2 RANBP2 RGPD8 FRMD7 CNKSR2 NIBAN2 PTPN4 RGPD3 EPB41 RASAL1

1.68e-04391139112.30.29.30
DomainLRRC37AB_C

LRRC37A3 LRRC37A2

3.27e-0441392IPR029423
DomainHeparan_SO4_deacetylase

NDST4 NDST3

3.27e-0441392IPR021930
DomainSirtuin_cat_small_dom

SIRT4 SIRT1

3.27e-0441392IPR026591
DomainLRRC37AB_C

LRRC37A3 LRRC37A2

3.27e-0441392PF14914
DomainLRRC37_N

LRRC37A3 LRRC37A2

3.27e-0441392IPR032754
DomainHSNSD

NDST4 NDST3

3.27e-0441392PF12062
DomainLRRC37

LRRC37A3 LRRC37A2

3.27e-0441392PF15779
Domain-

SIRT4 SIRT1

3.27e-04413923.30.1600.10
DomainKCL_cotranspt

SLC12A6 SLC12A4

3.27e-0441392IPR000076
DomainLRRC37A/B-like

LRRC37A3 LRRC37A2

3.27e-0441392IPR015753
DomainTPR-like_helical_dom

RGPD4 RGPD2 RANBP2 CLTCL1 RGPD8 PRPF6 RGPD3 RGPD5

3.61e-042331398IPR011990
DomainTPR

RGPD4 RGPD2 RANBP2 RGPD8 PRPF6 RGPD3

4.10e-041291396SM00028
DomainFERM_domain

FRMD7 JAK3 PTPN4 EPB41

4.80e-04491394IPR000299
DomainTPR_repeat

RGPD4 RGPD2 RANBP2 RGPD8 PRPF6 RGPD3

4.82e-041331396IPR019734
DomainEz/rad/moesin-like

FRMD7 PTPN4 EPB41

4.86e-04211393IPR000798
DomainFERM_1

FRMD7 JAK3 PTPN4 EPB41

5.19e-04501394PS00660
DomainFERM_2

FRMD7 JAK3 PTPN4 EPB41

5.19e-04501394PS00661
DomainFERM_3

FRMD7 JAK3 PTPN4 EPB41

5.19e-04501394PS50057
DomainBand_41_domain

FRMD7 JAK3 PTPN4 EPB41

5.19e-04501394IPR019749
DomainB41

FRMD7 JAK3 PTPN4 EPB41

5.19e-04501394SM00295
Domain-

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7 NLRC4 KDM2B KDM2A

6.80e-0432113993.80.10.10
DomainFERM_CS

FRMD7 PTPN4 EPB41

7.28e-04241393IPR019747
DomainL_dom-like

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7 NLRC4 KDM2B KDM2A

7.92e-043281399IPR032675
Domain-

RGPD4 RGPD2 RANBP2 CLTCL1 RGPD8 PRPF6 RGPD3

9.22e-0420713971.25.40.10
DomainFERM_C

FRMD7 PTPN4 EPB41

9.25e-04261393PF09380
DomainFERM_PH-like_C

FRMD7 PTPN4 EPB41

1.04e-03271393IPR018980
Domain-

ONECUT1 ONECUT3 CUX1

1.04e-032713931.10.260.40
DomainFERM_C

FRMD7 PTPN4 EPB41

1.04e-03271393SM01196
DomainSIR2

SIRT4 SIRT1

1.13e-0371392PF02146
DomainSsirtuin_cat_dom

SIRT4 SIRT1

1.13e-0371392IPR026590
DomainSirtuin

SIRT4 SIRT1

1.13e-0371392IPR003000
DomainSIRTUIN

SIRT4 SIRT1

1.13e-0371392PS50305
DomainSLC12A_fam

SLC12A6 SLC12A4

1.13e-0371392IPR004842
DomainLRR_1

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7 KDM2A

1.28e-032191397PF00560
DomainLambda_DNA-bd_dom

ONECUT1 ONECUT3 CUX1

1.28e-03291393IPR010982
DomainTPR_REGION

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.48e-031651396PS50293
DomainTPR

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.48e-031651396PS50005
DomainSLC12_C

SLC12A6 SLC12A4

1.50e-0381392IPR018491
DomainSLC12

SLC12A6 SLC12A4

1.50e-0381392PF03522
DomainFERM_N

FRMD7 PTPN4 EPB41

1.87e-03331393IPR018979
DomainFERM_N

FRMD7 PTPN4 EPB41

1.87e-03331393PF09379
DomainLRR_TYP

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7

2.11e-031771396SM00369
DomainLeu-rich_rpt_typical-subtyp

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7

2.11e-031771396IPR003591
DomainZF_CXXC

KDM2B KDM2A

2.89e-03111392PS51058
DomainPNT

ETS2 EHF

2.89e-03111392PS51433
DomainSAM_PNT

ETS2 EHF

2.89e-03111392PF02198
Domain-

SIRT4 SIRT1

2.89e-031113923.40.50.1220
DomainZnf_CXXC

KDM2B KDM2A

2.89e-03111392IPR002857
Domainzf-CXXC

KDM2B KDM2A

2.89e-03111392PF02008
DomainPointed_dom

ETS2 EHF

2.89e-03111392IPR003118
DomainSAM_PNT

ETS2 EHF

2.89e-03111392SM00251
DomainDHS-like_NAD/FAD-binding_dom

SIRT4 SIRT1

3.46e-03121392IPR029035
Domain-

DNHD1 ABCA13 MFHAS1 ABCB5 NDST4 CHD9 RFC5 URGCP NLRC4 NDST3 PSTK DNAH5 DHX29

3.80e-03746139133.40.50.300
DomainLRR

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7

3.97e-032011396PS51450
DomainLeu-rich_rpt

LRWD1 LRRC37A3 MFHAS1 LRRC37A2 LRRC59 TLR7 KDM2A

4.21e-032711397IPR001611
DomainTPR_1

RANBP2 RGPD8 PRPF6 RGPD5

4.58e-03901394IPR001440
DomainTPR_1

RANBP2 RGPD8 PRPF6 RGPD5

4.58e-03901394PF00515
DomainDynein_HC_stalk

DNHD1 DNAH5

4.72e-03141392IPR024743
DomainDynein_heavy_dom-2

DNHD1 DNAH5

4.72e-03141392IPR013602
DomainDHC_N2

DNHD1 DNAH5

4.72e-03141392PF08393
DomainMT

DNHD1 DNAH5

4.72e-03141392PF12777
DomainuDENN

DENND1C DENND2C

4.72e-03141392SM00800
DomainFERM_M

FRMD7 PTPN4 EPB41

4.85e-03461393PF00373
DomainDHC_fam

DNHD1 DNAH5

5.42e-03151392IPR026983
DomainuDENN

DENND1C DENND2C

5.42e-03151392PF03456
DomainDynein_heavy

DNHD1 DNAH5

5.42e-03151392PF03028
DomainDynein_heavy_dom

DNHD1 DNAH5

5.42e-03151392IPR004273
Domain-

FRMD7 PTPN4 EPB41

5.79e-034913931.20.80.10
DomainFERM_central

FRMD7 PTPN4 EPB41

5.79e-03491393IPR019748
DomainFERM/acyl-CoA-bd_prot_3-hlx

FRMD7 PTPN4 EPB41

6.12e-03501393IPR014352
DomainDENN

DENND1C DENND2C

6.16e-03161392SM00799
DomainDENN

DENND1C DENND2C

6.16e-03161392PF02141
DomaindDENN

DENND1C DENND2C

6.16e-03161392PF03455
DomainUDENN

DENND1C DENND2C

6.16e-03161392PS50946
DomainDDENN

DENND1C DENND2C

6.16e-03161392PS50947
DomaindDENN

DENND1C DENND2C

6.16e-03161392SM00801
DomaindDENN_dom

DENND1C DENND2C

6.16e-03161392IPR005112
PathwayREACTOME_NUCLEAR_ENVELOPE_BREAKDOWN

RGPD4 RGPD2 RANBP2 VRK2 RGPD8 AAAS RGPD3

1.38e-07551037MM14917
PathwayBIOCARTA_RANBP2_PATHWAY

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.50e-07181035MM1549
PathwayREACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

4.12e-07401036MM14945
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

4.80e-07411036MM15200
PathwayREACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

5.57e-07421036MM15039
PathwayREACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

6.43e-07431036MM14609
PathwayREACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 AAAS RGPD3

9.93e-07731037MM14948
PathwayREACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

1.11e-06471036MM14939
PathwayREACTOME_GENE_SILENCING_BY_RNA

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

1.42e-06491036MM14837
PathwayREACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

1.61e-06501036MM14610
PathwayREACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

1.81e-06511036MM15151
PathwayREACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

3.91e-06581036MM15149
PathwayREACTOME_SNRNP_ASSEMBLY

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

3.91e-06581036MM14736
PathwayREACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS

RGPD4 RGPD2 RANBP2 RGPD8 SIRT1 AAAS RGPD3

4.77e-06921037MM14951
PathwayREACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

7.66e-06651036MM15147
PathwayREACTOME_MITOTIC_PROPHASE

RGPD4 RGPD2 RANBP2 VRK2 RGPD8 AAAS RGPD3

1.96e-051141037MM15361
PathwayREACTOME_METABOLISM_OF_CARBOHYDRATES

RGPD4 RGPD2 FUT10 RANBP2 RGPD8 NDST4 ST3GAL4 NDST3 AAAS RGPD3

2.86e-0527110310MM15406
PathwayREACTOME_GLUCOSE_METABOLISM

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

2.94e-05821036MM15394
PathwayREACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

3.37e-05841036MM14929
PathwayREACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

3.85e-05861036MM15413
PathwayPID_IL2_PI3K_PATHWAY

JAK3 PIK3CA PRKCZ IL2RG

1.05e-04341034M143
PathwayWP_IL2_SIGNALING_PATHWAY

ETS2 JAK3 PIK3CA PRKCZ IL2RG

4.34e-04871035MM15915
PathwayWP_IL4_SIGNALING

FLNA JAK3 PIK3CA IL2RG

6.42e-04541034M39720
Pubmed

Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-11714559037092
Pubmed

Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145521205196
Pubmed

Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145524403063
Pubmed

Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145523536549
Pubmed

Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145512191015
Pubmed

Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145522821000
Pubmed

Complex genomic rearrangements lead to novel primate gene function.

RGPD4 RGPD2 RGPD8 RGPD3 RGPD5

2.45e-117145515710750
Pubmed

Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145511353387
Pubmed

Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145530944974
Pubmed

Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145538838144
Pubmed

Retina-specifically expressed novel subtypes of bovine cyclophilin.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-11714557559465
Pubmed

Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145517372272
Pubmed

Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145538657106
Pubmed

Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145518949001
Pubmed

Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145525187515
Pubmed

Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-11714558603673
Pubmed

Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145526632511
Pubmed

Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145523818861
Pubmed

Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.45e-117145520682751
Pubmed

The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.52e-118145521670213
Pubmed

Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.52e-118145527412403
Pubmed

Mice lacking Ran binding protein 1 are viable and show male infertility.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.52e-118145521310149
Pubmed

The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.52e-118145522262462
Pubmed

Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

6.52e-118145528745977
Pubmed

Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145528100513
Pubmed

Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145517887960
Pubmed

The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-10914559733766
Pubmed

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145518394993
Pubmed

The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145511553612
Pubmed

The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145510601307
Pubmed

Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.46e-109145528877029
Pubmed

Parkin ubiquitinates and promotes the degradation of RanBP2.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.91e-1010145516332688
Pubmed

The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.91e-1010145527160050
Pubmed

Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.91e-101014558857542
Pubmed

Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.91e-1010145521859863
Pubmed

RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

5.32e-1011145517069463
Pubmed

T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

5.32e-1011145534110283
Pubmed

An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

5.32e-1011145535771867
Pubmed

Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

1.47e-0913145531427429
Pubmed

Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.41e-0915145514697343
Pubmed

Peering through the pore: nuclear pore complex structure, assembly, and function.

RGPD4 RGPD2 RANBP2 RGPD8 AAAS RGPD3

1.17e-0838145612791264
Pubmed

Systematic identification of factors for provirus silencing in embryonic stem cells.

RGPD4 RGPD2 RANBP2 RGPD8 ELP1 PRPF6 RFC5 SIRT1 RGPD3

1.77e-08153145926365490
Pubmed

Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

2.92e-0822145527717094
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

RGPD4 TNPO1 RGPD2 RANBP2 REXO4 RGPD8 POLR2A TOPBP1 PRPF6 RGPD3 PWP2 TP53

5.59e-083701451222922362
Pubmed

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.

SIRT1 IL2RG TP53

7.10e-083145322340598
Pubmed

Identification of a novel Ran binding protein 2 related gene (RANBP2L1) and detection of a gene cluster on human chromosome 2q11-q12.

RANBP2 RGPD8 RGPD5

2.83e-07414539480752
Pubmed

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.

RGPD4 RGPD2 FLNA RGPD8 RGPD3 DHX29 EPB41 CUX1 RGPD5

3.27e-07215145935973513
Pubmed

Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice.

RRN3P2 RRN3 TP53

7.05e-075145319036968
Pubmed

Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.

RRN3P2 RRN3 TP53

7.05e-075145321228155
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

RANBP2 LRWD1 POLR2A ELP1 PRPF6 VPS16 RFC5 AAAS WDHD1 UBE3A RGPD3 ASNS DNAH5 DHX29

1.62e-067041451429955894
Pubmed

The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 TP53

1.69e-0686145637253089
Pubmed

A unique enhancer boundary complex on the mouse ribosomal RNA genes persists after loss of Rrn3 or UBF and the inactivation of RNA polymerase I transcription.

RRN3P2 RRN3 TP53

2.45e-067145328715449
Pubmed

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.

RGPD4 RGPD2 RANBP2 RGPD8 RFC5 RGPD3

3.86e-0699145627746211
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

TNPO1 ELP1 LRRC59 PRPF6 VPS16 TSPYL1 RFC5 ASNS PWP2 TOMM40 MED23 TP53

4.39e-065601451235241646
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

TNPO1 FLNA RANBP2 VRK2 MFHAS1 LRRC59 NIBAN2 SLC12A4 RGPD3 DHX29 EPB41 CUX1

5.06e-065681451237774976
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

TNPO1 RANBP2 POLR2A CHD9 LRRC59 PRPF6 RFC5 SIRT1 WDHD1 UBE3A ASNS PWP2 GINS2 KDM2A MED23 TP53

5.59e-0610141451632416067
Pubmed

Sirt3 protects in vitro-fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest.

SIRT4 SIRT1 TP53

5.85e-069145320644252
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 TNPO1 DNHD1 FLNA RANBP2 REXO4 POLR2A ELP1 LRRC59 PRPF6 RFC5 AAAS ASNS PWP2 TOMM40 MED23 DNAH5 DHX29 TP53

7.96e-0614251451930948266
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RGPD4 SLC12A6 RGPD2 FLNA RANBP2 CLTCL1 RGPD8 ABCB5 ATP10B LRRC59 PRPF6 MINDY2 PTK7 SLC12A4 RGPD3 PWP2 CUX1 BAHCC1 RGPD5

9.40e-0614421451935575683
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

TNPO1 FLNA RANBP2 LPCAT1 VRK2 SLC19A2 ELP1 LRRC59 TSPYL1 URGCP PTK7 AAAS ATP2C1 UBE3A ASNS

1.00e-059421451531073040
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

RGPD4 FLNA RANBP2 RGPD8 LRRC59 PRPF6 RFC5 RGPD3 CHMP3 CUX1 TP53 RGPD5

1.34e-056261451233644029
Pubmed

Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.

RRN3P2 RRN3 TP53

1.52e-0512145315989966
Pubmed

A Novel Mechanism for NF-κB-activation via IκB-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation.

RANBP2 POLR2A ELP1 TP53

1.72e-0537145432912968
Pubmed

SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation.

SIRT1 TP53

1.73e-052145224751483
Pubmed

SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.

SIRT1 TP53

1.73e-052145224726431
Pubmed

[Determination of the binding site of testis-specific nucleoporin BS-63 to transportin (karopherin beta 2) and the proof of their combination in vitro].

TNPO1 RGPD5

1.73e-052145212905863
Pubmed

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.

PIK3CA TP53

1.73e-052145228427202
Pubmed

Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.

KDM2B KDM2A

1.73e-052145232901907
Pubmed

High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast.

PIK3CA TP53

1.73e-052145229537649
Pubmed

Arterial calcification is driven by RAGE in Enpp1-/- mice.

ENPP1 AGER

1.73e-052145221099228
Pubmed

A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.

PIK3CA TP53

1.73e-052145231781598
Pubmed

Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

SIRT1 AGER

1.73e-052145222908267
Pubmed

Surface plasmon resonance imaging protein arrays for analysis of triple protein interactions of HPV, E6, E6AP, and p53.

UBE3A TP53

1.73e-052145216493710
Pubmed

A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genes.

SIRT1 TP53

1.73e-052145222124156
Pubmed

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.

PIK3CA TP53

1.73e-052145225220666
Pubmed

p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo.

POLR2A TP53

1.73e-052145221829606
Pubmed

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

PIK3CA TP53

1.73e-052145229714670
Pubmed

Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.

RRN3P2 RRN3

1.73e-052145230918302
Pubmed

Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.

UBE3A TP53

1.73e-05214528380895
Pubmed

Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

SIRT1 TP53

1.73e-052145215780941
Pubmed

The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.

VRK2 TP53

1.73e-052145216704422
Pubmed

An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer.

PIK3CA TP53

1.73e-052145236563059
Pubmed

KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.

SIRT1 KDM2B

1.73e-052145229763382
Pubmed

Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia.

SLC12A6 SLC12A4

1.73e-052145231835175
Pubmed

Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.

JAK3 IL2RG

1.73e-052145232921793
Pubmed

Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.

PIK3CA TP53

1.73e-052145234876602
Pubmed

Cell cycle progression following naive T cell activation is independent of Jak3/common gamma-chain cytokine signals.

JAK3 IL2RG

1.73e-052145219734221
Pubmed

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

UBE3A TP53

1.73e-05214521661671
Pubmed

Biological Functions of the KDM2 Family of Histone Demethylases.

KDM2B KDM2A

1.73e-052145237751135
Pubmed

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.

PIK3CA TP53

1.73e-052145237344660
Pubmed

Acetylation is indispensable for p53 antiviral activity.

SIRT1 TP53

1.73e-052145222033337
Pubmed

Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice.

JAK3 IL2RG

1.73e-052145210653847
Pubmed

The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma.

PIK3CA TP53

1.73e-052145233290961
Pubmed

N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.

SIRT1 TP53

1.73e-052145230447351
Pubmed

Exercise training ameliorates early diabetic kidney injury by regulating the H2 S/SIRT1/p53 pathway.

SIRT1 TP53

1.73e-052145234396581
Pubmed

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients.

PIK3CA TP53

1.73e-052145229434452
Pubmed

Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.

UBE3A TP53

1.73e-052145236298868
Pubmed

The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing.

UBE3A TP53

1.73e-05214529143503
Pubmed

Role of the SIRT1/p53 regulatory axis in oxidative stress‑mediated granulosa cell apoptosis.

SIRT1 TP53

1.73e-052145233179088
Pubmed

Intratumoral heterogeneity for inactivating frameshift mutation of CUX1 and SIRT1 genes in gastric and colorectal cancers.

SIRT1 CUX1

1.73e-052145229363918
InteractionRGPD4 interactions

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

7.48e-09221426int:RGPD4
InteractionRGPD2 interactions

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

2.88e-08271426int:RGPD2
InteractionRGPD3 interactions

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

9.32e-07471426int:RGPD3
InteractionRGPD1 interactions

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.20e-06491426int:RGPD1
InteractionRGPD5 interactions

RGPD4 TNPO1 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

5.25e-06961427int:RGPD5
InteractionRGPD8 interactions

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

1.38e-05741426int:RGPD8
GeneFamilyCUT class homeoboxes and pseudogenes

ONECUT1 ONECUT3 CUX1

1.05e-059923527
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD5

2.65e-05115926769
GeneFamilySirtuins

SIRT4 SIRT1

5.29e-047922938
GeneFamilyZinc fingers CXXC-type

KDM2B KDM2A

1.64e-0312922136
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

FRMD7 PTPN4 EPB41

2.10e-03509231293
GeneFamilyWD repeat domain containing

LRWD1 WDR83 AAAS WDHD1 PWP2 IFT80

2.20e-03262926362
GeneFamilyExonucleases

REXO4 EXO5

2.93e-0316922544
GeneFamilyF-box and leucine rich repeat proteins

KDM2B KDM2A

5.05e-0321922558
CoexpressionGAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP

RGPD4 RGPD2 RANBP2 RGPD8 ENPP1 RGPD3

2.53e-08331456MM477
CoexpressionTABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING

RGPD4 RGPD2 RANBP2 RGPD8 RGPD3

3.93e-06431455MM3857
ToppCell(7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

LPCAT1 CYBRD1 CYP17A1 ETS2 SLC34A2 C16orf89 ATP2C1 FGGY EPB41

1.95e-08199145909cf004032e5af912ee0cdde6e24ce3bcf7673cd
ToppCellParenchymal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LPCAT1 SLC34A2 NIBAN2 C16orf89 AGER EHF PRKCZ DNAH5 FGGY

2.04e-08200145916828c6a2be66bbbd805453325d6da719f2dea1b
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

2.04e-071891458b55de812043b670cbde810d7d42f45909b6d66ef
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

2.04e-0718914584e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type

TRAF3IP2 LPCAT1 SLC34A2 NUDT13 ZDHHC23 AGER PRKCZ ADGRF1

2.79e-0719714586b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCellBiopsy_Control_(H.)-Epithelial-Transitional_AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

LPCAT1 CYBRD1 SLC34A2 NIBAN2 PTK7 C16orf89 AGER PRKCZ

3.02e-071991458e04a57a55c724091db353e2b3baf84372d788728
ToppCellASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

LPCAT1 CYBRD1 SLC34A2 C16orf89 FAM216B EHF DNAH5 FGGY

3.14e-072001458cb617e2a0ca82b470b473b8d5906bc8879c85718
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

VRK2 PTK7 NDST3 SLC12A4 ZDHHC23 RASAL1 SEZ6

1.05e-0616214574d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCellFetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TRPM6 ABCA13 ETS2 FAT2 EHF TMEM150C ADGRF1

1.34e-0616814576521bead9789d626b86cbd08692c621c5a5aef33
ToppCellFetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TRPM6 ABCA13 ETS2 FAT2 EHF TMEM150C ADGRF1

1.39e-061691457c3ee781735a9288ce1822b230d39bb91c1415589
ToppCellfacs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C21orf58 ODAD2 SERPINA11 FAM216B CCDC180 DNAH5 ELMOD1

1.89e-0617714573cfde67b93f3986312f5e74e42504214d966e7dc
ToppCellfacs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C21orf58 ODAD2 SERPINA11 FAM216B CCDC180 DNAH5 ELMOD1

1.89e-06177145712a52a12a87a31e501ced611f46a90d172ca7e35
ToppCellPND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

TRPM6 LPCAT1 SLC34A2 C16orf89 FAT2 AGER EHF

2.36e-06183145723e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCellPND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass

TRPM6 LPCAT1 SLC34A2 C16orf89 FAT2 AGER EHF

2.36e-0618314570a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCellPND07-28-samps-Epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

TRPM6 C21orf58 SLC34A2 C16orf89 AGER EHF DNAH5

2.36e-061831457a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCellCiliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

CFAP107 ABCA13 C21orf58 ODAD2 FAM216B TEX26 AGBL2

2.54e-0618514574fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LPCAT1 CYBRD1 SLC34A2 NIBAN2 C16orf89 PRKCZ FGGY

2.73e-0618714577c44cec1c26ca5907a495f2d7e633410e2e9728f
ToppCell368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 C16orf89 AGER EHF ADGRF1 FGGY

2.92e-0618914576f2322d017b74a1757c81d6e06f50ead8c3dd0cc
ToppCellEpithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4)

TCEA3 C21orf58 ODAD2 FAM216B CCDC180 DNAH5 ELMOD1

2.92e-0618914570bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCellPND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 ODAD2 FAM216B AGBL2 DNAH5 ELMOD1

2.92e-06189145738cde34295566a4ecaf7d0a81c5a192cf17d0459
ToppCellAT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

LPCAT1 SLC34A2 NIBAN2 PTK7 C16orf89 ADGRF1 FGGY

2.92e-0618914572d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 C16orf89 AGER EHF ADGRF1 FGGY

2.92e-061891457926b5fa3064b501a57ba78583e8af33532add455
ToppCell368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 C16orf89 AGER EHF ADGRF1 FGGY

3.03e-061901457459811e88d3001816c2d89034e0921c24918c17f
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-0619114577b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCellBAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-0619114579f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

3.13e-061911457bda8faf92495c8b362850c0aff4fc6fbdd9c563b
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

3.13e-0619114576880fb348bb0915db9a5da4f3566ca9ff93ed258
ToppCellHealthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ABCA13 SLC34A2 C16orf89 FAM216B TEX26 ADGRF1 DNAH5

3.13e-06191145728caedb2e448e0c7f494100d714fa7cdcf150691
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

RGPD2 RANBP2 ZDHHC23 PIK3CA KDM2A MED23 RGPD5

3.13e-0619114571ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457b4e335e798c9617356b8e24412f9270c42dce656
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457c4b223b33c020a064f576711a3d700eb60a2d737
ToppCellBAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-0619114575129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCellBAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCellHealthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ABCA13 SLC34A2 C16orf89 FAM216B TEX26 ADGRF1 DNAH5

3.13e-06191145715b9386b26caaa7d15f704c4a18881e1ce918a21
ToppCellControl-Epithelial|Control / Disease group,lineage and cell class (2021.01.30)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457b78547dae8328244a47c83346447bdd787efbcae
ToppCellHealthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ABCA13 SLC34A2 C16orf89 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde
ToppCellBAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCellControl-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30)

CFAP107 ABCA13 SLC34A2 FAM216B TEX26 ADGRF1 DNAH5

3.13e-061911457cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 ODAD2 FAM216B AGBL2 DNAH5 ELMOD1

3.13e-06191145796483adb97c81208aa513782550acd8a08b63866
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

3.24e-061921457b5cdc2dae3154b1e4ade88f841f38584402ffe33
ToppCellPND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TCEA3 C21orf58 FAM216B AGBL2 CCDC180 DNAH5 ELMOD1

3.24e-0619214572d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56
ToppCellASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

CFAP107 ABCA13 C21orf58 ODAD2 FAM216B AGBL2 DNAH5

3.36e-061931457a0baa8be6f590b2031fede22be588715ae458e93
ToppCellNS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

3.47e-0619414571ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCellwk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CFAP107 C21orf58 ODAD2 FAM216B EHF TEX26 DNAH5

3.47e-061941457b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCellCOVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class

CFAP107 ABCA13 ODAD2 FAM216B TEX26 CCDC180 DNAH5

3.47e-06194145743be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABCA13 ATP10B FAM216B TEX26 ADGRF1 CCDC180 DNAH5

3.59e-061951457d211a836cf711fdb91b10d512f09d462be937cc5
ToppCellmoderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

3.59e-061951457e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCellcellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LPCAT1 CYBRD1 SLC34A2 C16orf89 AGER PRKCZ FGGY

3.72e-061961457a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LPCAT1 CYBRD1 SLC34A2 C16orf89 AGER PRKCZ FGGY

3.72e-06196145769f27c2668a9f412b2eb6ca83d11b44863209542
ToppCellControl_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP107 ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

3.97e-061981457e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 CYBRD1 SLC34A2 NIBAN2 C16orf89 AGER FGGY

3.97e-06198145785215015bb86ada0e871c413a4ecdc903a3785ca
ToppCellControl_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP107 ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

3.97e-061981457e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCellLPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type

ATP10B ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

3.97e-061981457e035380578c01b0243bfef29ca9b50cc17cce771
ToppCellLPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type

ATP10B ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

3.97e-061981457ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type

C21orf58 CYP17A1 ODAD2 TEX26 ADGRF1 CCDC180 DNAH5

3.97e-0619814576d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 CYBRD1 SLC34A2 NIBAN2 C16orf89 AGER FGGY

3.97e-06198145738349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LPCAT1 SLC34A2 NIBAN2 C16orf89 AGER PRKCZ FGGY

4.11e-0619914577ebd89dff457f57a549eecee288c7a4b515b4018
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CFAP107 ATP10B ODAD2 C16orf89 ADGRF1 CCDC180 DNAH5

4.11e-06199145760919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CFAP107 C21orf58 ODAD2 FAM216B ADGRF1 CCDC180 DNAH5

4.11e-06199145715f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCellASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

TCEA3 LPCAT1 CYBRD1 SLC34A2 C16orf89 AGER EHF

4.11e-061991457ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7
ToppCellLPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CFAP107 ATP10B ODAD2 C16orf89 ADGRF1 CCDC180 DNAH5

4.11e-0619914576aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

4.25e-06200145752aef65f01b06cd98056f17977efe525aee6eb6f
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

4.25e-06200145755c148238d5c80c1faa3428a917ae8075be2c145
ToppCellLPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CFAP107 ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

4.25e-062001457cf191104484bfb2b9f87de416b9453135f8833c1
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ABCA13 SLC34A2 C16orf89 EHF ADGRF1 DNAH5 FGGY

4.25e-06200145721d9cf3cd3696ad6b745c7c036798f04b6ce5160
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

4.25e-06200145731d75c26055177d656df1fbb10b764cebd61e122
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ATP10B ODAD2 FAM216B EHF ADGRF1 CCDC180 DNAH5

4.25e-062001457da12821e8a0657869ca0f75d351cce2d7605a505
ToppCellLPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CFAP107 ODAD2 C16orf89 EHF ADGRF1 CCDC180 DNAH5

4.25e-062001457a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCellLPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CFAP107 ODAD2 FAM216B TEX26 ADGRF1 CCDC180 DNAH5

4.25e-0620014574992dbf0514d674017315dbd20d91dfec0c608e9
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP107 C21orf58 ODAD2 FAM216B AGBL2 CCDC180 DNAH5

4.25e-062001457e1dce91c6c531bb212002a14705e496d77ad3490
ToppCellLung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ABCA13 SLC34A2 C16orf89 EHF ADGRF1 DNAH5 FGGY

4.25e-06200145733658d5d09e2eaff60f4dd88837d4252328eab63
ToppCellParenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

ABCA13 SLC34A2 C16orf89 EHF ADGRF1 DNAH5 FGGY

4.25e-062001457d5426cd318a8f90c0bd8f9804351ab230fafc995
ToppCellLPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ATP10B ODAD2 FAM216B EHF ADGRF1 CCDC180 DNAH5

4.25e-06200145772c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCellCerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32

C16orf89 JAK3 RASIP1 UBA7 DENND2C IL2RG

8.12e-06145145637580218f6a6f65a1d827cbcf59465f8827f9a55
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ODAD2 FAM216B EHF ADGRF1 CCDC180 DNAH5

1.64e-051641456e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCellICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type

ABCB5 LRRC37A2 IL23A GINS2 AGBL2 BAHCC1

1.75e-05166145696d92316cee20b722fe782db9dafcceb8f2c220b
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 C16orf89 AGER EHF FGGY

1.88e-051681456e20e1936573fdde78426d7a4eb45c458d5c4dbb4
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 C16orf89 AGER EHF FGGY

1.88e-05168145616b517e3159ad6e6d25fd48f7d5f46e77b2b318d
ToppCellCOVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters

DNHD1 RGPD8 TLR7 NUDT13 ZDHHC23 RGPD3

1.94e-0516914566abfdc8b437f19c03b408bedc245059d28c6ba6a
ToppCellP07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LPCAT1 SLC34A2 RFC5 C16orf89 AGER GINS2

1.94e-0516914561a47a4892a5e6a69555f5332308503526e5422a7
ToppCellTCGA-Cervix|World / Sample_Type by Project: Shred V9

RFC5 RASIP1 FAT2 WDHD1 DENND2C GINS2

2.01e-051701456a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9

SLC12A6 PEX13 ANKRD50 FAT2 DENND2C EHF

2.07e-051711456adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

ABCA13 C21orf58 ODAD2 FAM216B TEX26 DNAH5

2.14e-051721456187ae91148d293537afc77e10da2b64302322224
ToppCelldroplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 ONECUT1 AGBL2 DNAH5

2.21e-051731456f3f67531f72d6d52e19c7f1f2db1ab4026fb70da
ToppCelldroplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 ONECUT1 AGBL2 DNAH5

2.21e-051731456a40a52d8041d45dc3bef74fe55945ae07aa018d6
ToppCelldroplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 ONECUT1 AGBL2 DNAH5

2.21e-051731456f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 FAM216B DNAH5 ELMOD1

2.60e-05178145658857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 FAM216B DNAH5 ELMOD1

2.60e-0517814568b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP107 C21orf58 ODAD2 FAM216B DNAH5 ELMOD1

2.60e-051781456b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCell390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 ATP10B C16orf89 ADGRF1 FGGY

2.68e-051791456466da2bc3bfc534ffe111c8c28ece7a3cfa08051
ToppCell390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells)

LPCAT1 SLC34A2 ATP10B C16orf89 ADGRF1 FGGY

2.68e-051791456f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd
ToppCell3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TCEA3 ATP10B ST3GAL4 EHF FGGY RASAL1

2.68e-051791456ec331b1132f965581f851a3b29e62873c4140e6c
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LPCAT1 CYBRD1 SLC34A2 C16orf89 PROZ AGER

2.68e-051791456bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCellfacs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C21orf58 ODAD2 FAM216B CCDC180 DNAH5 ELMOD1

2.77e-051801456cf6e9f757afeb342c5023f6e6152a1b4d0d164b4
ToppCellP03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TCEA3 C21orf58 ODAD2 FAM216B DNAH5 ELMOD1

2.85e-0518114561ea21d860d4d7abab3e21e130a16d044006656ee
ToppCellAT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

LPCAT1 SLC34A2 NIBAN2 PTK7 ADGRF1 FGGY

2.85e-051811456ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCellP03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TCEA3 C21orf58 ODAD2 FAM216B DNAH5 ELMOD1

2.85e-05181145660a91587c59029a34e7bec1255083337fe21b72a
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

EPHX2 RGPD2 CNKSR2 NIBAN2 MINDY2 UBE3A

2.85e-0518114569275531e896e118cee043ed94fd31a0070d9581c
ToppCellCOVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type

LPCAT1 PGGHG SLC34A2 TTLL7 AGER PRKCZ

3.04e-0518314567b1a385ed54f93bfe85bf0c162e42d05d516b45c
DiseaseAdenocarcinoma of large intestine

PTK7 PIK3CA TBCK PRKCZ CUX1 TP53

6.42e-06961396C1319315
DiseaseMalignant neoplasm of penis

PIK3CA TP53

1.31e-0441392C0153601
DiseasePenile Neoplasms

PIK3CA TP53

1.31e-0441392C0030849
Diseaseepilepsy (is_marker_for)

FLNA SIRT1

1.31e-0441392DOID:1826 (is_marker_for)
Diseasetongue squamous cell carcinoma (biomarker_via_orthology)

JAK3 TP53

3.26e-0461392DOID:0050865 (biomarker_via_orthology)
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD9 TP53

4.56e-0471392DOID:0050834 (implicated_via_orthology)
Diseasedisease of cellular proliferation (implicated_via_orthology)

JAK3 TP53

4.56e-0471392DOID:14566 (implicated_via_orthology)
DiseaseClinically Isolated Syndrome, CNS Demyelinating

SIRT1 TP53

6.06e-0481392C2350037
DiseaseDemyelinating Diseases

SIRT1 TP53

6.06e-0481392C0011303
DiseaseDemyelination

SIRT1 TP53

6.06e-0481392C0011304
DiseaseHEPATOCELLULAR CARCINOMA

PIK3CA TP53

7.76e-0491392114550
DiseaseAdult Hepatocellular Carcinoma

PIK3CA TP53

7.76e-0491392C0279607
DiseaseHepatocellular carcinoma

PIK3CA TP53

7.76e-0491392cv:C2239176
DiseaseGlioma

ELP1 TP53

7.76e-0491392cv:C0017638
DiseaseCutaneous Melanoma

PIK3CA CUX1 TP53

9.57e-04411393C0151779
DiseaseHead and Neck Carcinoma

PIK3CA TP53

9.67e-04101392C3887461
Diseasegastric adenocarcinoma (is_implicated_in)

ABCA13 TP53

1.18e-03111392DOID:3717 (is_implicated_in)
DiseaseAdenoid Cystic Carcinoma

ST3GAL4 PIK3CA GINS2 TP53

1.30e-031001394C0010606
DiseaseB-Cell Lymphomas

JAK3 TP53

1.41e-03121392C0079731
Diseasetotal lipids in small LDL

ST3GAL4 NYNRIN TOMM40

1.43e-03471393EFO_0022168
Diseasephospholipids in medium LDL measurement

ST3GAL4 NYNRIN TOMM40

1.61e-03491393EFO_0022183
Diseasecholesterol in medium LDL measurement

ST3GAL4 NYNRIN TOMM40

1.61e-03491393EFO_0022224
Diseasehematologic cancer (implicated_via_orthology)

JAK3 CUX1

1.66e-03131392DOID:2531 (implicated_via_orthology)
Diseasemiddle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement

CNKSR2 TOMM40

1.66e-03131392EFO_0006514, EFO_0010316
DiseaseCiliopathies

PCARE IFT80 DNAH5 USH2A

1.85e-031101394C4277690
DiseaseColorectal Carcinoma

MYOT ABCA13 ABCB5 CNKSR2 NDST3 PIK3CA KDM2A PRKCZ CUX1 TP53

1.86e-0370213910C0009402
Diseasetotal lipids in medium LDL

ST3GAL4 NYNRIN TOMM40

1.91e-03521393EFO_0022180
DiseaseSquamous cell carcinoma of the head and neck

PIK3CA TBCK TP53

1.91e-03521393C1168401
Diseasetotal lipids in LDL measurement

ST3GAL4 NYNRIN TOMM40

1.91e-03521393EFO_0022308
DiseaseKartagener syndrome (implicated_via_orthology)

ODAD2 DNAH5

1.93e-03141392DOID:0050144 (implicated_via_orthology)
Diseasesevere combined immunodeficiency (is_implicated_in)

JAK3 IL2RG

1.93e-03141392DOID:627 (is_implicated_in)
DiseaseAdenocarcinoma Of Esophagus

PIK3CA TP53

1.93e-03141392C0279628
DiseaseSarcoma, Spindle Cell

PIK3CA TP53

1.93e-03141392C0205945
DiseaseSarcoma, Epithelioid

PIK3CA TP53

1.93e-03141392C0205944
DiseaseChronic Lymphocytic Leukemia

TOPBP1 PIK3CA TP53

2.24e-03551393C0023434
Diseaseneuroblastoma

VRK2 NYNRIN DNAH5 TP53

2.25e-031161394EFO_0000621
DiseasePsoriasis

TRAF3IP2 IL23A TP53

2.49e-03571393C0033860
DiseaseAlzheimer's disease (implicated_via_orthology)

SIRT1 AGER TOMM40

2.49e-03571393DOID:10652 (implicated_via_orthology)
DiseasePustulosis of Palms and Soles

TRAF3IP2 IL23A TP53

2.49e-03571393C0030246
DiseaseNeuralgia, Supraorbital

CYP17A1 AGER

2.53e-03161392C0038870
DiseaseNeuralgia

CYP17A1 AGER

2.53e-03161392C0027796
DiseaseNeuralgia, Atypical

CYP17A1 AGER

2.53e-03161392C0234247
DiseaseNeuralgia, Stump

CYP17A1 AGER

2.53e-03161392C0234249
DiseaseNeuralgia, Iliohypogastric Nerve

CYP17A1 AGER

2.53e-03161392C0423712
DiseaseNeuralgia, Perineal

CYP17A1 AGER

2.53e-03161392C0423711
DiseaseParoxysmal Nerve Pain

CYP17A1 AGER

2.53e-03161392C0751373
DiseaseNerve Pain

CYP17A1 AGER

2.53e-03161392C0751372
DiseaseNeuralgia, Ilioinguinal

CYP17A1 AGER

2.53e-03161392C0751371
DiseaseNeuralgia, Vidian

CYP17A1 AGER

2.53e-03161392C0042656
Diseasecholesterol in IDL measurement

ST3GAL4 RRN3 TOMM40

2.61e-03581393EFO_0021899
Diseasephospholipids in LDL measurement

ST3GAL4 NYNRIN TOMM40

2.61e-03581393EFO_0022294
Diseasephospholipids in small LDL measurement

ST3GAL4 NYNRIN TOMM40

2.74e-03591393EFO_0022297
Diseasefree cholesterol in IDL measurement

ST3GAL4 RRN3 TOMM40

3.02e-03611393EFO_0022181
Diseasealkaline phosphatase measurement

REXO4 PGGHG MFHAS1 ST3GAL4 ONECUT1 DALRD3 RASIP1 AAAS SLC17A1 FAM216B NYNRIN TOMM40

3.15e-03101513912EFO_0004533
DiseaseHypertrophy

SIRT1 AGER

3.21e-03181392C0020564
DiseaseMammary Carcinoma, Human

FLNA CYP17A1 LRRC37A2 ETS2 ELP1 SIRT1 PIK3CA TP53

3.52e-035251398C4704874
DiseaseMammary Neoplasms, Human

FLNA CYP17A1 LRRC37A2 ETS2 ELP1 SIRT1 PIK3CA TP53

3.52e-035251398C1257931
DiseaseOmenn Syndrome

JAK3 IL2RG

3.57e-03191392C2700553
DiseaseMammary Neoplasms

FLNA CYP17A1 LRRC37A2 ETS2 ELP1 SIRT1 PIK3CA TP53

3.60e-035271398C1458155
Diseaseatherosclerosis (biomarker_via_orthology)

SIRT1 AGER

3.96e-03201392DOID:1936 (biomarker_via_orthology)
DiseaseSevere Combined Immunodeficiency

JAK3 IL2RG

3.96e-03201392C0085110
DiseaseBreast Carcinoma

FLNA CYP17A1 LRRC37A2 ETS2 ELP1 SIRT1 PIK3CA TP53

4.07e-035381398C0678222
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

MFHAS1 ST3GAL4 SLC12A4 RRN3 TOMM40

4.34e-032251395EFO_0008317, EFO_0020947
DiseaseBREAST CANCER

PIK3CA TP53

4.36e-03211392114480
DiseaseSarcoma

PIK3CA TP53

4.36e-03211392C1261473
Diseasecardiovascular system disease (is_implicated_in)

ENPP1 AGER

4.36e-03211392DOID:1287 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
LSNLNKRKRPPWKIT

nan

526

A8MVM7
NLIPKEILWRPKEAF

ASNS

456

P08243
KLRINRFPWPKVLKI

EPB41

426

P11171
RPKISAFLPARQLWK

BAHCC1

2471

Q9P281
QWINLPVLQLTKDPL

AAAS

41

Q9NRG9
PPKELVNEWSLKIRK

CHMP3

11

Q9Y3E7
REKWAQEPLLQPLSL

C16orf89

76

Q6UX73
LWKFLKPNTPLESRI

ELMOD1

141

Q8N336
RPQWKRPKEPNSTIL

CYBRD1

221

Q53TN4
RNFLKLLKPPLLWSH

ADGRF1

66

Q5T601
VSEILARPKPWNKLT

CUX1

586

P39880
VSLLKILKLNKPEWP

ABCB5

676

Q2M3G0
KRQQKLWNVPQLPFI

FAM216B

6

Q8N7L0
LLQNLPQWPALKRFL

ABCA13

431

Q86UQ4
PPWLLLLCSARKQSK

ANKRD50

226

Q9ULJ7
WQKKPQMDLISPLLL

DNHD1

2791

Q96M86
DVIRKLLQLPNTKWP

CCDC180

1256

Q9P1Z9
QFLIDWVRKNLPKSP

DHX29

381

Q7Z478
SLPNIPRWQPDDKKL

DENND1C

596

Q8IV53
KPPRNWKDSILTKNL

ATP2C1

761

P98194
KLPPDKRNLEIQSWR

ATP10B

1336

O94823
KLGQPLPSWLRQELQ

NDST3

856

O95803
TLQQKPPKGWFRLLP

RASAL1

221

O95294
APKKPPQRLEWKLNT

AGER

41

Q15109
VGLWINSPRKQLAKL

RASIP1

21

Q5U651
SLPALPGIRKWLKQL

RANBP2

446

P49792
NSLPALPGIRKWLKQ

RGPD5

446

Q99666
NSLPALPGIRKWLKQ

RGPD8

446

O14715
WKNKDIQRLLPSPLK

INTS9

156

Q9NV88
RQQLPAPKWTELALL

JAK3

741

P52333
NPRWLDPNKPIRKQL

PTPN4

81

P29074
TGLPQAQLLWRKVPL

NIBAN2

51

Q96TA1
LLPAALQAPTQILKW

LRWD1

591

Q9UFC0
KPISLQNWKRGLDIL

EXO5

56

Q9H790
QPPALWRKVVDFLLK

LPCAT1

86

Q8NF37
PAKALPQVRDRWKDL

LRRC37A3

1261

O60309
PAKALPQVRDRWKDL

LRRC37A2

1261

A6NM11
VPQLVKLGLKNWRLT

NLRC4

906

Q9NPP4
PPQWLSETRNSKKRL

GPR176

461

Q14439
RVGLWKIKDNPLIQP

MFHAS1

366

Q9Y4C4
KWLDLKDNPLDPVLA

LRRC59

111

Q96AG4
PKWIKHSLPDIQLLQ

MMRN1

946

Q13201
WLELLKPITKQVKNP

FRMD7

56

Q6ZUT3
WNSLVPVRLQVVPKK

FAT2

2671

Q9NYQ8
PTDKLRALPLWLSLQ

PDXDC2P

331

Q6P474
KKEQRRLGIPKNPWL

ETS2

91

P15036
TLSDLLRNPKPWSKL

ONECUT1

326

Q9UBC0
WKLDPATLRFPLKGL

MED23

241

Q9ULK4
PDQFQRLLKINPDWK

METTL9

131

Q9H1A3
IPPKINRRTQWKLSL

ELP1

1316

O95163
FLRQKWNDPRLKLPS

GLRB

106

P48167
LAVLQWLQLPKDERP

ENPP1

351

P22413
DLWKLLPENNVLSPL

TP53

21

P04637
LPIPSQWLAVADKIK

PGGHG

461

Q32M88
LGQPLPSWLRQELQK

NDST4

856

Q9H3R1
IKKEQLSGSPWILLR

MLKL

196

Q8NB16
WLPPKLAISHQLIKE

NUDT13

326

Q86X67
IPEILPKLLLSVKWN

PIK3CA

561

P42336
KLKWRLFSRVPPTLN

PDP2

36

Q9P2J9
NSLPALPGIRKWLKQ

RGPD3

446

A6NKT7
RLDRPPSNIWKKIDQ

CHD9

836

Q3L8U1
IIKPLQPNAKVLQWK

IFT80

171

Q9P2H3
QILIKWLDSDARNPP

EPHX2

536

P34913
KKQLTWLVNRLPGLK

KDM2A

966

Q9Y2K7
ISKKQLSWLINRLPG

KDM2B

1136

Q8NHM5
LRKPWKLDRQKLPSP

C21orf58

11

P58505
QAPKLLWLKENLREI

FGGY

146

Q96C11
RLLGWIQNKLPQLPI

FLNA

171

P21333
NLLNVPKPLPKQLWE

CRTC3

216

Q6UUV7
WANIRLQEKGLPPKR

FUT10

396

Q6P4F1
ILLNPDKNPGLIKWE

EHF

216

Q9NZC4
DLVPWLKIFPNKTLE

CYP17A1

216

P05093
KLLWLPEKSDFPLLA

CFAP107

121

Q8N1D5
SPSQPWQRLLLRFKI

IL23A

151

Q9NPF7
LIPDTLQKEKLLWPI

AGBL2

66

Q5U5Z8
SQILWKKIEALPPDK

DENND2C

146

Q68D51
LKLQNLVIPWAPENL

IL2RG

146

P31785
PPKLLQQVLKKITFW

KLHDC1

366

Q8N7A1
LLWQKLVDKAPLRQK

DALRD3

296

Q5D0E6
LGDLVSILKLPQWLK

FAAH

401

O00519
PQWLKGLLAFLVKPL

FAAH

411

O00519
HTKNWRPQLLVLLKL

SLC12A6

751

Q9UHW9
PKPDRLLVLKVLWND

SLC19A2

271

O60779
PLLIDPQTQGKIWIK

DNAH5

3601

Q8TE73
EKPWAGTLQRPVKLL

PNLIPRP2

31

P54317
PLNLEWKQKELAPLP

NYNRIN

411

Q9P2P1
LAWPLKKREPQEQPN

PCARE

251

A6NGG8
LSDLLRNPKPWSKLK

ONECUT3

356

O60422
ILNVLLLAWKVKLPP

MINDY2

271

Q8NBR6
WLLKQKSQAPEKPLV

REXO4

76

Q9GZR2
LWKKLQDPSNPAIIR

RRN3

386

Q9NYV6
LLLSWNPPKKANGII

USH2A

2071

O75445
NSLPALPGIRKWLKQ

RGPD4

446

Q7Z3J3
SLPALPGIRKWLKQL

RGPD2

446

P0DJD1
QPAATKIRNLPWVEK

RFC5

11

P40937
KLQDLWRTCQKLPPQ

ARHGAP17

356

Q68EM7
LEKSRLKNPKNPGLW

PRPF6

766

O94906
LKNPKNPGLWLESVR

PRPF6

771

O94906
PKIQWRLQERLKAPT

TAF1C

551

Q15572
RLLWSLLKNPHPDVK

ODAD2

841

Q5T2S8
QSLPIKAILKSLPVW

SLC17A1

251

Q14916
NLKQRQKCRLLPPEW

GINS2

51

Q9Y248
KQPPLIWDVNPKQIR

ST3GAL4

216

Q11206
WQIVINILSEPPKRK

SIRT1

221

Q96EB6
WEKKLPIAILNIGPT

SIRT4

276

Q9Y6E7
LALKEQQPKVRGWLL

PEX13

301

Q92968
RAPDLQDLPWQVKLT

PROZ

181

P22891
RFIQLKPKVLNPWLN

TMEM150C

86

B9EJG8
KPKVLNPWLNISGLV

TMEM150C

91

B9EJG8
PPIWRVQKALLQKFT

PRR12

1601

Q9ULL5
RKQWRLQQPILKLAL

MRGPRX2

286

Q96LB1
HTKNWRPQLLVLLKL

SLC12A4

686

Q9UP95
QWPLPKQKLEALHLL

ERVK-9

961

P63128
WPKNKKNILLRLLRE

TRAF3IP2

541

O43734
KRNRLKLLLPWLESQ

CLTCL1

851

P53675
ALLKNMRWKPLALQP

CNKSR2

306

Q8WXI2
QSRCPRVLPKKLQNW

SLC34A2

576

O95436
RVLPKKLQNWNFLPL

SLC34A2

581

O95436
QAVLAPLKPALWTRL

RINL

351

Q6ZS11
PKDLPWNFLRKLQAL

URGCP

111

Q8TCY9
LPLAAQGKLIRLWSK

UBE3A

316

Q05086
KNSWLKIIISIILPP

TRPM6

741

Q9BX84
GVPDLNTRLLVKKLW

SPO11

251

Q9Y5K1
LWQLIKSALPPAAIV

SMIM9

61

A6NGZ8
DWTALRELLKLLPQP

UBA7

746

P41226
LQPQTLRKWGQLLLP

SERPINA11

291

Q86U17
KIAEIIKEDLWPNPL

TSPYL1

391

Q9H0U9
LKPPAGWKADLLQRE

PWP2

226

Q15269
RLAWQPKSGKLLAIP

WDHD1

191

O75717
PAPSQWKLLRQELLK

PSTK

71

Q8IV42
QPAILKPRPLWTGKQ

POLR2A

576

P24928
PIALLRNPWRKEKAA

VPS16

46

Q9H269
PKWSDRAPKCLLEQL

SEZ6

821

Q53EL9
LIKNWKRLLDSPGPP

TCEA3

71

O75764
LQWKKVALLNPIENP

STIMATE

176

Q86TL2
PLWKKLQDPSNPAII

RRN3P2

271

A6NIE6
KNQIWKEARVDIPPL

TBCK

456

Q8TEA7
DKTLKLWNPLRGTLL

WDR83

46

Q9BRX9
PPRWFKNINKLQELD

TLR7

306

Q9NYK1
LLQNIWKAEPATLLP

USP38

201

Q8NB14
LQNWPDLLPKLCSLL

TNPO1

131

Q92973
WLRGAKKVNISIIPP

ZDHHC23

81

Q8IYP9
EKRLPPWKKRTLNQV

nan

236

Q3C1V9
NWIVGATLEKKLPPL

TOMM40

321

O96008
LSLEWKKLLPQPPDT

TEX26

166

Q8N6G2
RSNRNVPWDLKLEKP

ZNF354A

111

O60765
PLIQWKGKDRILDPT

PTK7

621

Q13308
NLKKPILLPSWIKTL

TOPBP1

161

Q92547
NLLDELPQSVLKWAP

VRK2

266

Q86Y07
RKLKPWLLEINRAPS

TTLL7

341

Q6ZT98
IDWDLLEKKQALPPF

PRKCZ

521

Q05513
QISAIPPPKLFWKRN

MYOT

371

Q9UBF9